Author: Woo, Yeonju; Hyun, Min Kyung
Title: Effectiveness of Integrative Therapy for Parkinson’s Disease Management Document date: 2019_2_26
ID: 08tmmlgg_15
Snippet: To adjust for biomedicine treatment in both treatment groups, the treatment period in neurology, hospitalization period in neurology and anti-parkinsonism medications (levodopa, ropinirole, pramipexole, selegiline) were also considered as confounders (Zhuo et al., 2017) . The propensity score (PS) was used to increase the level of causality revealed in the observational study (D'Agostino, 1998) . Specifically, the PS was used to match the subject.....
Document: To adjust for biomedicine treatment in both treatment groups, the treatment period in neurology, hospitalization period in neurology and anti-parkinsonism medications (levodopa, ropinirole, pramipexole, selegiline) were also considered as confounders (Zhuo et al., 2017) . The propensity score (PS) was used to increase the level of causality revealed in the observational study (D'Agostino, 1998) . Specifically, the PS was used to match the subjects with similar characteristics in the two groups. Several variables were used to create the PS index: age, sex, index year, CCI, treatment period in neurology, hospitalization period in neurology, severity of disability and anti-parkinsonism medication. Comparison of the PS between groups was repeated using the greedy algorithm and 1: 1 matching continued until there were no more matching pairs (Parsons, 2001) . The PS fit was confirmed by c-statistics and the Hosmer and Lemeshow Goodness-of-Fit test. In the case of a c-statistic value over 0.5, the Hosmer and Lemeshow Goodness-of-Fit test was considered to be good when the p-value was 0.05 or higher (D'Agostino, 1998; Maldonado and Greenland, 2002) . The prevalence and annual length of hospitalization were analyzed using logistic regression analysis and t-tests. A pvalue < 0.05 was considered significant. Additionally, the integrative therapy group was divided into two groups by treatment period, less than 30 days and over 30 days. The prevalence and annual length of hospitalization were analyzed using logistic regression analysis and ANOVA. After ANOVA, Duncan's post hoc test was applied. A p-value < 0.05 was considered significant. Finally, survival analysis of the integrative therapy group and monotherapy group was performed using the Cox proportional hazard analysis.
Search related documents:
Co phrase search for related documents- anti parkinsonism medication and hospitalization annual length: 1
- anti parkinsonism medication and hospitalization annual length prevalence: 1
- anti parkinsonism medication and index year: 1
- anti parkinsonism medication and integrative therapy group: 1, 2
- anti parkinsonism medication and logistic regression: 1
- anti parkinsonism medication and monotherapy group: 1, 2
- anti parkinsonism medication and monotherapy group integrative therapy group: 1, 2
- anti parkinsonism medication and propensity score: 1
- anti parkinsonism medication and PS propensity score: 1
- anti parkinsonism medication and therapy group: 1, 2
- anti parkinsonism medication and treatment group: 1
- anti parkinsonism medication disability and biomedicine treatment: 1
- anti parkinsonism medication disability and hospitalization annual length: 1
- anti parkinsonism medication disability and hospitalization annual length prevalence: 1
- anti parkinsonism medication disability and index year: 1
- anti parkinsonism medication disability and integrative therapy group: 1
- anti parkinsonism medication disability and logistic regression: 1
- anti parkinsonism medication disability and monotherapy group: 1
- anti parkinsonism medication disability and monotherapy group integrative therapy group: 1
Co phrase search for related documents, hyperlinks ordered by date